AVNS - CIK 0001606498
AVANOS MEDICAL, INC. has filed 701 documents with the SEC between 2014 and 2026. The most frequent type is insider trade (300 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2024-02-20 | 2024-02-20 |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-13 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-09 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-07 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-01-22 | - |
| Insider trade | 4 | 2024-01-04 | 2024-01-03 |
| Insider trade | 4 | 2024-01-04 | 2024-01-03 |
| Insider trade | 4 | 2024-01-04 | 2024-01-03 |
| Insider trade | 4 | 2024-01-04 | 2024-01-03 |
| Insider trade | 4 | 2024-01-04 | 2024-01-03 |
| Major company event | 8-K | 2024-01-04 | 2024-01-04 |
| Insider trade | 4 | 2023-12-12 | 2023-12-11 |
| Quarterly report | 10-Q | 2023-11-01 | 2023-09-30 |
| Major company event | 8-K | 2023-11-01 | 2023-11-01 |
| Insider trade | 4 | 2023-10-31 | 2023-10-30 |
| Major company event | 8-K | 2023-10-02 | 2023-10-02 |
| Quarterly report | 10-Q | 2023-08-09 | 2023-06-30 |
| Major company event | 8-K | 2023-08-09 | 2023-08-09 |
| Major company event | 8-K | 2023-08-09 | 2023-08-09 |
| Major company event | 8-K | 2023-08-01 | 2023-07-28 |
| Insider trade | 4 | 2023-07-21 | 2023-07-20 |
| Employee stock plan | S-8 | 2023-07-13 | - |
| Major company event | 8-K | 2023-06-20 | 2023-06-19 |
| Major company event | 8-K | 2023-06-08 | 2023-06-07 |
| SD | - | 2023-05-25 | - |
| Insider trade | 4 | 2023-05-09 | 2023-05-08 |
| Insider trade | 4 | 2023-05-09 | 2023-05-08 |
| Insider trade | 4 | 2023-05-09 | 2023-05-08 |
| Quarterly report | 10-Q | 2023-05-03 | 2023-03-31 |
| Major company event | 8-K | 2023-05-03 | 2023-04-27 |
| Insider trade (amended) | 4/A | 2023-03-23 | 2023-03-06 |
| Insider trade (amended) | 4/A | 2023-03-23 | 2023-03-06 |
| Annual report to shareholders | ARS | 2023-03-17 | 2022-12-31 |
| Proxy materials | DEFA14A | 2023-03-17 | - |
| Proxy statement | DEF 14A | 2023-03-17 | - |
| New insider ownership | 3 | 2023-03-09 | 2023-03-06 |
| Insider trade | 4 | 2023-03-07 | 2023-03-06 |
| Insider trade | 4 | 2023-03-07 | 2023-03-06 |
| Insider trade | 4 | 2023-03-07 | 2023-03-06 |
| Insider trade | 4 | 2023-03-07 | 2023-03-06 |
| Insider trade | 4 | 2023-03-07 | 2023-03-06 |
| Insider trade | 4 | 2023-03-07 | 2023-03-06 |
| Insider trade | 4 | 2023-03-07 | 2023-03-06 |
| Insider trade | 4 | 2023-03-07 | 2023-03-06 |
| Major company event | 8-K | 2023-03-06 | 2023-02-28 |
| Annual report | 10-K | 2023-02-21 | 2022-12-31 |
| Major company event (amended) | 8-K/A | 2023-02-21 | 2023-01-10 |
| Major company event | 8-K | 2023-02-21 | 2023-02-21 |
| Major company event | 8-K | 2023-02-17 | 2023-02-14 |